Alzamend Neuro (ALZN) Competitors $3.53 +0.36 (+11.36%) Closing price 04:00 PM EasternExtended Trading$3.48 -0.04 (-1.27%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALZN vs. AEON, DWTX, GOVX, JBIO, CLRB, CHRO, KPRX, BMRA, TSBX, and TRAWShould you be buying Alzamend Neuro stock or one of its competitors? The main competitors of Alzamend Neuro include AEON Biopharma (AEON), Dogwood Therapeutics (DWTX), GeoVax Labs (GOVX), Jade Biosciences (JBIO), Cellectar Biosciences (CLRB), Chromocell Therapeutics (CHRO), Kiora Pharmaceuticals (KPRX), Biomerica (BMRA), Turnstone Biologics (TSBX), and Traws Pharma (TRAW). These companies are all part of the "pharmaceutical products" industry. Alzamend Neuro vs. Its Competitors AEON Biopharma Dogwood Therapeutics GeoVax Labs Jade Biosciences Cellectar Biosciences Chromocell Therapeutics Kiora Pharmaceuticals Biomerica Turnstone Biologics Traws Pharma AEON Biopharma (NASDAQ:AEON) and Alzamend Neuro (NASDAQ:ALZN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk. Which has stronger earnings & valuation, AEON or ALZN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAEON BiopharmaN/AN/A-$36.63M$298.120.00Alzamend NeuroN/AN/A-$9.95MN/AN/A Which has more volatility and risk, AEON or ALZN? AEON Biopharma has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Alzamend Neuro has a beta of -0.31, indicating that its stock price is 131% less volatile than the S&P 500. Do analysts prefer AEON or ALZN? AEON Biopharma currently has a consensus target price of $360.00, suggesting a potential upside of 46,351.61%. Alzamend Neuro has a consensus target price of $180.00, suggesting a potential upside of 4,999.15%. Given AEON Biopharma's higher possible upside, research analysts clearly believe AEON Biopharma is more favorable than Alzamend Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AEON Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Alzamend Neuro 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of AEON or ALZN? 22.8% of AEON Biopharma shares are owned by institutional investors. Comparatively, 49.6% of Alzamend Neuro shares are owned by institutional investors. 0.9% of AEON Biopharma shares are owned by insiders. Comparatively, 30.2% of Alzamend Neuro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to AEON or ALZN? In the previous week, AEON Biopharma and AEON Biopharma both had 1 articles in the media. Alzamend Neuro's average media sentiment score of 1.89 beat AEON Biopharma's score of 0.00 indicating that Alzamend Neuro is being referred to more favorably in the news media. Company Overall Sentiment AEON Biopharma Neutral Alzamend Neuro Very Positive Is AEON or ALZN more profitable? AEON Biopharma's return on equity of 0.00% beat Alzamend Neuro's return on equity.Company Net Margins Return on Equity Return on Assets AEON BiopharmaN/A N/A -994.63% Alzamend Neuro N/A -497.73%-147.21% SummaryAlzamend Neuro beats AEON Biopharma on 5 of the 8 factors compared between the two stocks. Get Alzamend Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for ALZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALZN vs. The Competition Export to ExcelMetricAlzamend NeuroMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.54M$2.91B$5.52B$9.32BDividend YieldN/A2.46%4.25%4.05%P/E RatioN/A20.3628.1519.68Price / SalesN/A304.13438.32100.43Price / CashN/A42.3835.5357.53Price / Book-0.117.768.235.67Net Income-$9.95M-$55.11M$3.23B$257.51M7 Day Performance15.36%0.95%-0.01%0.52%1 Month Performance14.24%8.44%5.61%8.84%1 Year Performance-90.12%-2.38%26.52%14.18% Alzamend Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALZNAlzamend Neuro2.7874 of 5 stars$3.53+11.4%$180.00+4,999.2%-90.6%$2.54MN/A0.004AEONAEON Biopharma2.4042 of 5 stars$0.81+2.6%$360.00+44,235.0%-99.5%$9.18MN/A4.515DWTXDogwood Therapeutics1.8698 of 5 stars$4.76+3.4%$10.00+110.3%N/A$9.09MN/A-0.265Gap UpGOVXGeoVax Labs2.2187 of 5 stars$0.55+10.5%$11.10+1,900.4%-75.4%$8.84M$3.95M-0.1510Analyst UpgradeHigh Trading VolumeJBIOJade Biosciences2.377 of 5 stars$10.40-0.5%$14.00+34.6%N/A$8.75MN/A-0.1720Analyst ForecastCLRBCellectar Biosciences2.5378 of 5 stars$4.83+0.6%$375.00+7,664.0%-93.8%$8.74MN/A-0.2210Gap UpCHROChromocell TherapeuticsN/A$1.34+6.3%N/A-88.5%$8.69MN/A-1.084Gap UpHigh Trading VolumeKPRXKiora Pharmaceuticals3.1788 of 5 stars$2.85+1.4%$10.00+250.9%-27.9%$8.68MN/A-0.9810News CoverageBMRABiomerica1.1342 of 5 stars$3.31-2.5%N/A+4.3%$8.50M$5.41M-1.4460Positive NewsTSBXTurnstone Biologics3.4079 of 5 stars$0.37+0.5%$0.45+22.6%-85.8%$8.49MN/A-0.1382Positive NewsTRAWTraws PharmaN/A$1.52+4.5%N/AN/A$8.42M$230K-0.0517News Coverage Related Companies and Tools Related Companies AEON Biopharma Competitors Dogwood Therapeutics Competitors GeoVax Labs Competitors Jade Biosciences Competitors Cellectar Biosciences Competitors Chromocell Therapeutics Competitors Kiora Pharmaceuticals Competitors Biomerica Competitors Turnstone Biologics Competitors Traws Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALZN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALZN Stock Alerts